Cargando…
Nuclear TEAD4 with SIX1 Overexpression is an Independent Prognostic Marker in the Stage I–III Colorectal Cancer
INTRODUCTION: Stage I–III colorectal cancer patients are under risk of tumor recurrence and metachronous metastasis after radical surgery. An increased expression of transcription factor TEAD4 is associated with epithelial-mesenchymal transition, metastasis and poor prognosis in colorectal cancer. H...
Autores principales: | Yu, Tong, Song, Jinglue, Zhou, Hui, Wu, Tingyu, Liang, Zhonglin, Du, Peng, Liu, Chen-Ying, Wang, Guanghui, Cui, Long, Liu, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898202/ https://www.ncbi.nlm.nih.gov/pubmed/33628048 http://dx.doi.org/10.2147/CMAR.S260790 |
Ejemplares similares
-
Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer
por: MASUDA, TAIKI, et al.
Publicado: (2016) -
VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle
por: Figeac, Nicolas, et al.
Publicado: (2019) -
Loss of nuclear localization of TET2 in colorectal cancer
por: Huang, Yuji, et al.
Publicado: (2016) -
PHF5A promotes colorectal cancerprogression by alternative splicing of TEAD2
por: Chang, Yue, et al.
Publicado: (2021) -
Nuclear actin regulates cell proliferation and migration via inhibition of SRF and TEAD
por: McNeill, Madeleine C., et al.
Publicado: (2020)